Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) FCF Margin (2017 - 2020)

Historic FCF Margin for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to 3290.71%.

  • Cogent Biosciences' FCF Margin fell 22921800.0% to 3290.71% in Q3 2020 from the same period last year, while for Jun 2021 it was 13945.51%, marking a year-over-year decrease of 137994500.0%. This contributed to the annual value of 455.47% for FY2020, which is 2708100.0% down from last year.
  • Cogent Biosciences' FCF Margin amounted to 3290.71% in Q3 2020, which was down 22921800.0% from 1576.52% recorded in Q2 2020.
  • Over the past 5 years, Cogent Biosciences' FCF Margin peaked at 55.32% during Q4 2019, and registered a low of 3290.71% during Q3 2020.
  • For the 4-year period, Cogent Biosciences' FCF Margin averaged around 636.15%, with its median value being 364.37% (2018).
  • The largest annual percentage gain for Cogent Biosciences' FCF Margin in the last 5 years was 2663800bps (2020), contrasted with its biggest fall of -22921800bps (2020).
  • Over the past 4 years, Cogent Biosciences' FCF Margin (Quarter) stood at 311.63% in 2017, then rose by 24bps to 237.06% in 2018, then surged by 77bps to 55.32% in 2019, then crashed by -5848bps to 3290.71% in 2020.
  • Its last three reported values are 3290.71% in Q3 2020, 1576.52% for Q2 2020, and 112.26% during Q1 2020.